share_log

Results: Zynex, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Results: Zynex, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

公司Zynex, Inc. 超出盈利預期,分析師現在有了新的預測。
Simply Wall St ·  10/26 22:12

Shareholders of Zynex, Inc. (NASDAQ:ZYXI) will be pleased this week, given that the stock price is up 14% to US$9.12 following its latest quarterly results. It looks like a credible result overall - although revenues of US$50m were what the analysts expected, Zynex surprised by delivering a (statutory) profit of US$0.07 per share, an impressive 24% above what was forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

zynex的股東們(納斯達克: ZYXI)本週將感到高興,因爲股價上漲了14%,至9.12美元,跟隨其最新的季度業績。總體上看起來是一個可靠的結果 - 儘管5千萬美元的營業收入符合分析師們的預期,zynex通過每股0.07美元的(法定)利潤交出了一個令人印象深刻的24%高於預期的成績。對於投資者來說,這是一個重要時刻,因爲他們可以追蹤公司的績效報告,查看專家們對明年的預測,並看看業務預期是否有任何變化。我們收集了最新的法定預測,以查看分析師們是否在這些結果之後修改了他們的盈利模型。

big
NasdaqGS:ZYXI Earnings and Revenue Growth October 26th 2024
納斯達克GS: ZYXI的盈利和營收增長2024年10月26日

Following the latest results, Zynex's three analysts are now forecasting revenues of US$239.6m in 2025. This would be a huge 24% improvement in revenue compared to the last 12 months. Per-share earnings are expected to jump 213% to US$0.47. Before this earnings report, the analysts had been forecasting revenues of US$242.6m and earnings per share (EPS) of US$0.50 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

根據最新的結果,zynex的三位分析師現在預測2025年的營業收入將達到23960萬美元。與過去12個月相比,這將是營收大幅提升24%。每股收益預計將飆升213%,至0.47美元。在這份盈利報告之前,分析師們曾預測2025年的營業收入將爲24260萬美元,每股收益(EPS)爲0.50美元。在最新的業績之後,分析師們似乎對該業務持有了更爲消極的看法,考慮到他們對明年每股收益數字有小幅下降。

It might be a surprise to learn that the consensus price target was broadly unchanged at US$17.50, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Zynex, with the most bullish analyst valuing it at US$24.50 and the most bearish at US$11.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

也許有些令人驚訝的是,共識價格目標基本保持在17.50美元不變,分析師們明顯表示盈利預期下降不太可能對估值產生太大影響。查看分析師估計範圍也會很有收穫,從而評估離群值的意見與平均值有多大不同。關於zynex,有一些不同的看法,其中最看好的分析師將其價值定爲24.50美元,而最看淡的則爲每股11.00美元。注意分析師價格目標之間的差距很大嗎?這對我們意味着潛在業務的可能情景範圍非常廣。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that Zynex's revenue growth is expected to slow, with the forecast 19% annualised growth rate until the end of 2025 being well below the historical 27% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 8.2% annually. Even after the forecast slowdown in growth, it seems obvious that Zynex is also expected to grow faster than the wider industry.

我們可以從更大的背景中看待這些估算,比如將預測與過去的業績進行對比,以及看看預測相對於行業其他公司是否更看好。我們要強調的是,Zynex的營業收入增長預計將放緩,預計到2025年年底的年增長率爲19%,遠低於過去五年的歷史27%的年增長率。 相比之下,行業其他有分析師覆蓋的公司預計每年營收增長率爲8.2%。 即使在預測增長放緩之後,顯而易見的是Zynex也預計比整個行業增長更快。

The Bottom Line

最重要的事情是分析師增加了它對下一年每股虧損的估計。令人欣慰的是,營收預測未發生重大變化,業務仍有望比整個行業增長更快。共識價格目標穩定在28.50美元,最新估計不足以對價格目標產生影響。

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

最重要的是,分析師下調了他們的每股收益估計,顯示在這些結果之後情緒明顯下降。令人欣慰的是,營收預測沒有發生重大變化,業務仍預計比整個行業增長更快。共識價格目標沒有真正發生變化,這表明企業的內在價值在最新預測中沒有經歷任何重大變化。

With that in mind, we wouldn't be too quick to come to a conclusion on Zynex. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Zynex analysts - going out to 2026, and you can see them free on our platform here.

考慮到這一點,我們不應該過快下結論關於Zynex。長期盈利能力比明年的利潤更重要。 我們有來自多個Zynex分析師的估算,延伸至2026年,您可以在我們的平台上免費查看。

Even so, be aware that Zynex is showing 3 warning signs in our investment analysis , you should know about...

即便如此,請注意,Zynex在我們的投資分析中顯示了3個警示信號,您應該了解...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論